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Papain is a thiol proteolytic enzyme widely used in dermatology
that found applications in wound treatment. Recently, papain was
also used as absorption enhancer which can modify the peptide/
protein material in the bilayer domain. We investigated papain safety
using human skin that was exposed to papain in vitro at different
times: 4, 24 and 48 hours. The samples were examined using Light
and Transmission Electron Microscopy (TEM) to study of the
mechanisms involved in enhancer-skin interaction. After 24 hours,
changes occurred in corneosomes. However, samples of 48 hours
did not show major changes in agreement with the control. These
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INTRODUCTION
Human skin, and specifically the stratum corneum, as
an effective and selective barrier, provides the major control
to chemical permeation (Barry, 2001; Elias, 2005; Baby et
al., 2006). The penetration process presents three potential
pathways to the viable tissue – through hair follicles with
associated sebaceous glands, via sweat ducts or across
continuous stratum corneum. The last one is the choice of
most of the compounds, which can bypass through the
corneocytes (transcellular microroute) or through regions
of the semicrystalline gel composed of multiple liquid
bilayers of ceramides, fatty acids, cholesterol and
cholesterol esters (intercellular microroute) (Barry, 2001).
The stratum corneum is regarded as a heterogeneous two-
compartment system composed of keratin-filled
corneocytes, embedded in a lipid-enriched intercellular
matrix. The lipid lamellae are formed by rearrangement of
lamellar disks that are extruded from the uppermost cells of
the stratum granulosum (Bergh et al., 1999).
Enzymes can interfere on the percutaneous absorption
of drugs by two ways: like a penetration enhancer or
producing a delayed absorption. Papain is a thiol proteolytic
enzyme widely used in dermatology that has found
application in wound treatment. Recently, papain was also
used as absorption enhancer which can modify the peptide/
protein material in the bilayer domain (Fein et al., 2005;
Pinto et al., 2007).
The stratum corneum contains several proteases that
may play a central role in the desquamation process. The first
enzyme discovered was Stratum Corneum Chymotryptic
Enzyme (SCCE ) followed by Stratum Corneum Tryptic
Enzyme (SCTE). Both of them may be involved in this
complex process (Marzulli, Maibach, 1996; Caubet et al.,
2004; Brattsand et al., 2005). Bernard and co-workers
(2003) have described a thiol protease, probably expressed
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as a pro-enzyme, in the lower layers of the epidermis and in
part activated by an unidentified mechanism in the upper
layers during differentiation of the keratinocytes. Therefore,
papain, a thiol protease, could be a safe penetration enhancer
candidate (Bernard et al., 2003).
The aim of this research work was to study the
possible behavior by which papain could act as a safe
penetration enhancer using Light and Transmission
Electron Microscopy (TEM).
MATERIAL AND METHODS
Human skin, obtained from breast plastic surgery,
was cleaned and cut in small pieces measuring 2 cm2 and
placed in 60 mm culture dishes, processed the same day of
the surgery. Subcutaneous fat was removed and the skin
cleaned with saline solution. A solution of 0.2% (w/v)
papain + 0.04% (w/v) cystein in KGM (keratinocytes
growth medium) was applied to the stratum corneum (1.96
cm2 – steel rings) for different periods of contact: 4, 24 and
48 h. A control was run at the same conditions, without
papain and cystein.
Skin samples were removed immediately following
the application period and were fixed in 5 mL of
Karnovsky’s fixative solution overnight at 25 °C. Samples
were washed in phosphate-buffered saline (PBS) pH 7.4 for
three times and post-fixed in 2% osmium tetroxide for 2 h
at 4 °C. A third fixative was used, 0.5% uranyl acetate, for
36 h. Following fixation, the specimens were washed and
dehydrated in a range of ethanol solutions (70, 80, 90, 95,
100%), changed in propylene oxide and embedded in 1 part
of propylene oxide and 1 part of Spurr’s resin. During
infiltration, the vials of tissue were gently shaken on a
turntable that positioned the vials at about 30° from the
vertical, and slowly rotated the tissue. This mixture was left
overnight and changed for Spurr’s resin for 4 h, changed
again and left for 1 h more at 37 °C. The final step in
embedding was curing the tissues blocks by polimerization
of the epoxy mixture. The resin was placed in polyethylene
capsules, and the tissue cube was placed into the resin to
gradually sink in the bottom for 5 days at 60 C. Thin
sections were done with ultramicrotome (Leica Ultracut®
UCT), using glass lamina followed by fixing with
chloroform which was evaporated in hot plate. Then, the
sections were stain with toluidine blue and they were
observed and photographed in the light microscope to de-
termine which ultrathin sections should be done. Ultrathin
sections (60 nm), obtained with diamond lamina, were
stained with 4% uranyl acetate alcoholic solution for 30-40
min and washed with ethanol, water, and next with 0.4%
lead citrate for 3 min. Grids of 200 mesh were examined in
a JEOL 1010 transmission electron microscope and
photographed with Kodak Electron Microscope – Estar
thick base 4489, 100, 8.3 x 10.2 cm and stored in the
laboratory computer. The protocols for the sample
preparations were the same used in the Anatomy
Department of Biomedical Institute of Sciences – ICB III.
The experiments have been carried out under approval
of Ethic Committee of Department of Pharmacy at
University of São Paulo, Brazil (CEP/ FCF/USP n º 229).
RESULTS AND DISCUSSION
According to the results, corneosomes (or corneo-
desmosomes) were affected by papain when compared to
control. Figure 1 illustrates the untreated epidermis
(control). Corneosomes in untreated epidermis was
characterized by an extracellular electron dense plug,
which merged imperceptibly with the outer lipid envelope
leaflets of corneocytes (Figure 1B).
Corneodesmosomes are intercellular junctions of the
tissue from the molecular modification of desmosomes and
persist in the stratum corneum up to its surface (Haftek et
al., 1999). The desmosome or macula adherens forms
plaque-like structures that, in thin sections, have an
appearance similar to the zonula adherens, but the
desmosome contains a definite intermediate dense line that
lines within the intercellular space and parallels the cell
surface (Bozzola, Russel, 1992).
The stratum corneum proteins are extensive
crosslinked with both cell envelope and intracellular
proteins. Therefore, increased diffusion across the
corneocytes should have resulted from alterations in its
structure. A decrease in crosslinking density at the cell en-
velope would allow diffusivity enhancement through cell
(Suhonen et al., 1999).
Proteolytic digestion, after 24 h papain 0.2% (w/v)
contact, induced dramatic changes (Figure 2). A large
amount of the intercellular material was lost in the first
layer of stratum corneum. Corneosomes, identified by
rudiments of their attachment plaques, were devoid of their
plug material, most of the extracellular components were
digested and corneocytes were separated (Figure 2B).
Details of corneodesmosomes released are showed in Figu-
re 3, where it can be seen the amount of tonofilaments,
intermediate filaments usually composed of keratin, that
make hairpins turns at the junctional density (Bozzola,
Russel, 1992).
The ultra structural appearance of corneodesmosomes
suggested that they were modified during the transition
between viable epidermis and cornified epidermal layers.
Part of this change may be explained to the incorporation of
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proteins. One of this is corneodesmosin, a 52-kD protein that
is specifically expressed in cornified epidermal layer. It is
found intracellularly in association with lamellar bodies, in
the stratum granulosum and in the transition zone between
the stratum granulosum and the stratum corneum, coinciding
with the change in ultrastructural appearance of the
desmosomes, when corneodesmosin is translocated to the
extracellular parts of desmosomes and is continuously
degraded to smaller constituents of the stratum corneum
(Marzulli, Maibach, 1996).
After 48 h, the contents of outer edges corneocytes
were leached, but the cell adhesion was still maintained by
corneosomes (Figure 4A). The first layer remained
unscathed although the next ones showed lower contact
(Figure 4B). TEM micrographs of epithelia treatment
during 48 h (Figure 4B), showed that the upper layer of the
stratum corneum had no changes, while those on keratin
cytoesqueletal appeared only in the second layer. As well,
it was possible to see the corneodesmosomes maintenance.
The stratum corneum recovery happened after 48 h of
treatment, as is shown in Figure 5, where it is possible to note
the existence of a major number of cells in each layer.
FIGURE 1 - (A) Light microscope micrograph of human epidermis. (B) Transmission electron micrograph of control,
untreated epidermis. The corneosomes are characterized by an extracellular electron dense plug (black arrow).
FIGURE 2 - (A) Light microscope micrograph of human epidermis after 24h papain treatment. (B) Transmission electron
micrograph of 24h enzymatic treatment disrupts the corneosome bond (arrow) and modified the superficial stratum
corneum layer.
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The cause of these in vitro changes is unknown, but
they may reflect activation of endogenous mechanisms that
could neutralize or recover the corneocytes adhesion. These
results were substantiated with cell culture and corroborated
data from biophysics techniques, like differential scanning
calorimetry (DSC), attenuated total reflectance Fourier
transform infrared spectroscopy (ATR-FTIR), photoacustic
spectroscopy (PAS) and Fourier transform Raman
spectroscopy (FT-Raman) (data not showed).
The desquamation process is controlled by specifics
enzymes, which hydrolyzed corneodesmosomes releasing
the dead cells in skin surface. It is precisely controlled by
a cascade of events, a molecular mechanism that is not
completely known (Bernard et al., 2003). It has been shown
that these specific enzymes are produced in keratinocytes.
The thiol group present in the active site of these enzymes
is responsible for cleaving the peptide bond, more
efficiently than triglycolic acid and cystein (Egelrud, 2000).
Papain, as a thiol proteolytic enzyme, could be acting in the
same way that these enzymes.
According to the results, TEM micrographs of
epithelia after treatment during 24 h using papain, showed
changes in the stratum corneum cohesion, this structures
lost integrity (Figure 3). On the other hand, treatment
during 48 h showed no changes in the upper layer of the
stratum corneum (Figure 4).
CONCLUSION
Papain 0.2% (w/v) promoted a proteolytic digestion
of stratum corneum first layers and induced a decreased
crosslinking in corneosomes region. In the treated samples,
after 48 h, the stratum corneum was recovered. These
results suggested that papain could be used safely used due
to reversibility of barrier function of stratum corneum.
FIGURE 3 - Transmission electron micrograph of human
skin after treatment during 24 hours using papain 0.2% (p/
v). Arrow indicates an amount of tonofilaments.
FIGURE 4 - (A) Light microscope micrograph of human epidermis after 48h papain treatment. (B) Transmission electron
micrograph of stratum corneum first layers after 48 hours. Corneosomes bonds (black arrow) appeared recovered.
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RESUMO
Avaliação in vitro da segurança de uso da papaína em
pele humana: Estudo qualitativo por microscopia de
luz e eletrônica de transmissão (MET)
Papaína é uma enzima proteolítica amplamente utilizada
na dermatologia para o tratamento de feridas. Atualmen-
te, a papaína também tem sido empregada como promo-
tor de absorção cutânea passível de modificar os domíni-
os protéicos da epiderme. Nesta pesquisa investigou-se in
vitro a segurança da papaína, utilizando pele humana
exposta a enzima em diferentes períodos de tempo de con-
tato: 4, 24 e 48 horas. As amostras foram avaliadas por
Microscopia de Luz e Eletrônica de Transmissão (MET),
técnicas que podem ser utilizadas no estudo dos mecanis-
mos envolvidos na interação de promotores de absorção
cutânea e a pele. Após 24 horas de contato entre a pele a
solução de papaína, mudanças ocorreram nos
corneossomos, no entanto, as amostras em contato por 24
horas não evidenciaram alterações relevantes compara-
das com o controle. Os resultados indicaram que a
papaína poderia ser seguramente aplicada sobre a pele.
UNITERMOS: Microscopia eletrônica de transmissão/
análise qualitativa. Microscopia óptica/análise qualitati-
va. Extrato córneo. Papaína/ uso cosmético. Pele huma-
na/cosmetologia.
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